Linda H Malkas Selected Research

Linda H Malkas Research Topics

Disease

33	Neoplasms (Cancer) 10/2023 - 02/2005
12	Neuroblastoma 12/2015 - 02/2005
10	Breast Neoplasms (Breast Cancer) 03/2015 - 08/2002
4	Adenocarcinoma 06/2020 - 01/2007
2	Genomic Instability 10/2023 - 01/2014
2	Carcinogenesis 02/2008 - 11/2002
1	Necrosis 10/2021
1	Pancreatic Neoplasms (Pancreatic Cancer) 06/2020
1	Triple Negative Breast Neoplasms 02/2015
1	Glioblastoma (Glioblastoma Multiforme) 01/2014
1	Ovarian Neoplasms (Ovarian Cancer) 10/2013
1	Prostatic Intraepithelial Neoplasia 05/2011
1	Prostatic Neoplasms (Prostate Cancer) 05/2011
1	Barrett Esophagus (Barrett's Esophagus) 01/2007
1	Ataxia Telangiectasia (Louis Bar Syndrome) 10/2005
1	Lung Neoplasms (Lung Cancer) 02/2005
1	Infections 08/2002
1	Myotoxicity 08/2002

Drug/Important Bio-Agent (IBA)

15	Proliferating Cell Nuclear Antigen (PCNA)IBA 10/2023 - 09/2006
9	Protein Isoforms (Isoforms)IBA 01/2023 - 09/2006
9	Peptides (Polypeptides)IBA 01/2023 - 01/2006
8	Proteins (Proteins, Gene)FDA Link 06/2020 - 11/2002
8	Biomarkers (Surrogate Marker)IBA 06/2015 - 02/2005
5	DNA (Deoxyribonucleic Acid)IBA 10/2023 - 01/2006
3	DNA synthesomeIBA 01/2016 - 07/2005
3	Phosphotransferases (Kinase)IBA 01/2013 - 10/2005
3	Blood Proteins (Serum Proteins)IBA 10/2007 - 04/2006
2	Reactive Oxygen Species (Oxygen Radicals)IBA 01/2023 - 02/2008
2	Amino Acids FDA Link 06/2020 - 11/2014
2	Cisplatin (Platino)FDA LinkGeneric 12/2018 - 11/2014
2	Small Interfering RNA (siRNA)IBA 03/2015 - 06/2012
2	polyacrylamideIBA 09/2009 - 02/2005
1	Radioisotopes (Radionuclides)IBA 10/2021
1	Cell-Penetrating PeptidesIBA 06/2020
1	Dosage Forms (Dosage Form)IBA 12/2018
1	RNA (Ribonucleic Acid)IBA 06/2015
1	Ribonucleotide Reductases (Ribonucleotide Reductase)IBA 06/2015
1	AntimetabolitesIBA 06/2015
1	Glutamic Acid (Glutamate)FDA Link 03/2015
1	EnzymesIBA 03/2015
1	MethyltransferasesIBA 03/2015
1	Arginine (L-Arginine)FDA Link 02/2015
1	berbamine (penduline)IBA 01/2014
1	DNA-Directed DNA Polymerase (Polymerases, DNA)IBA 10/2013
1	purineIBA 10/2013
1	pyrimidineIBA 10/2013
1	NucleotidesIBA 10/2013
1	TOR Serine-Threonine KinasesIBA 01/2013
1	tyrosine receptor (receptor, tyrosine)IBA 01/2013
1	Phosphatidylinositol 3-Kinase (1 Phosphatidylinositol 3 Kinase)IBA 01/2013
1	ChromatinIBA 06/2012
1	Nuclear Proteins (Protein, Nuclear)IBA 03/2011
1	Doxorubicin (Adriamycin)FDA LinkGeneric 09/2009
1	RNA primersIBA 04/2009
1	SugarsIBA 07/2008
1	Polysaccharides (Glycans)IBA 07/2008
1	Oxidants (Oxidizing Agents)IBA 02/2008
1	AntioxidantsIBA 02/2008
1	AlbuminsIBA 10/2007
1	Immunoglobulin kappa-Chains (kappa-Chain, Immunoglobulin)IBA 10/2007
1	Acute-Phase Proteins (Acute-Phase Protein)IBA 10/2007
1	DNA Polymerase IIIIBA 12/2006
1	Mitogen-Activated Protein KinasesIBA 07/2006
1	Phosphopyruvate Hydratase (Enolase)IBA 04/2006
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 04/2006
1	Serum-Free Culture MediaIBA 01/2006
1	U 0126 (UO 126)IBA 01/2006
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2006
1	Ataxia Telangiectasia Mutated ProteinsIBA 10/2005
1	A-Form DNA (A-DNA)IBA 07/2005
1	Glucose (Dextrose)FDA LinkGeneric 02/2005
1	DNA Polymerase iotaIBA 08/2004
1	PoisonsIBA 08/2002

Therapy/Procedure

9	Therapeutics 10/2021 - 01/2006
2	Drug Therapy (Chemotherapy) 10/2021 - 11/2014
2	Lasers (Laser) 09/2009 - 08/2007